140 related articles for article (PubMed ID: 33717678)
21. Aqueous Humor Markers in Retinoblastoma, a Review.
Ghiam BK; Xu L; Berry JL
Transl Vis Sci Technol; 2019 Apr; 8(2):13. PubMed ID: 31019846
[TBL] [Abstract][Full Text] [Related]
22. SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy.
Li X; Zhang W; Song J; Zhang X; Ran L; He Y
Clin Epigenetics; 2019 Jul; 11(1):99. PubMed ID: 31288850
[TBL] [Abstract][Full Text] [Related]
23. Co-deleting Pten with Rb in retinal progenitor cells in mice results in fully penetrant bilateral retinoblastomas.
Xie C; Lu H; Nomura A; Hanse EA; Forster CL; Parker JB; Linden MA; Karasch C; Hallstrom TC
Mol Cancer; 2015 Apr; 14():93. PubMed ID: 25907958
[TBL] [Abstract][Full Text] [Related]
24. Trefoil Family Factor Peptide 1-A New Biomarker in Liquid Biopsies of Retinoblastoma under Therapy.
Busch MA; Haase A; Alefeld E; Biewald E; Jabbarli L; Dünker N
Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835522
[TBL] [Abstract][Full Text] [Related]
25. Serum exosomal miRNA as biomarkers for Retinoblastoma.
Ravishankar H; Mangani AS; Phoebe Moses GL; Mani SP; Parameswaran S; Khetan V; Ganesan S; Krishnakumar S
Exp Eye Res; 2020 Oct; 199():108184. PubMed ID: 32795526
[TBL] [Abstract][Full Text] [Related]
26. Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer.
Guo L; Huang C; Ji QJ
Bratisl Lek Listy; 2017; 118(3):164-168. PubMed ID: 28319413
[TBL] [Abstract][Full Text] [Related]
27. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
28. Next-Generation Technologies and Strategies for the Management of Retinoblastoma.
Gudiseva HV; Berry JL; Polski A; Tummina SJ; O'Brien JM
Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835688
[TBL] [Abstract][Full Text] [Related]
29. Cell-Free DNA as a Diagnostic Blood-Based Biomarker for Colorectal Cancer: A Systematic Review.
Petit J; Carroll G; Gould T; Pockney P; Dun M; Scott RJ
J Surg Res; 2019 Apr; 236():184-197. PubMed ID: 30694754
[TBL] [Abstract][Full Text] [Related]
30. Highly sensitive detection of DNA hypermethylation in melanoma cancer cells.
Nesvet J; Rizzi G; Wang SX
Biosens Bioelectron; 2019 Jan; 124-125():136-142. PubMed ID: 30366258
[TBL] [Abstract][Full Text] [Related]
31. The RB protein family in retinal development and retinoblastoma: new insights from new mouse models.
Bremner R; Chen D; Pacal M; Livne-Bar I; Agochiya M
Dev Neurosci; 2004; 26(5-6):417-34. PubMed ID: 15855771
[TBL] [Abstract][Full Text] [Related]
32. Aberrant CpG methylation of the TFAP2A gene constitutes a mechanism for loss of TFAP2A expression in human metastatic melanoma.
Hallberg AR; Vorrink SU; Hudachek DR; Cramer-Morales K; Milhem MM; Cornell RA; Domann FE
Epigenetics; 2014 Dec; 9(12):1641-7. PubMed ID: 25625848
[TBL] [Abstract][Full Text] [Related]
33. Genome-wide identification of OTP gene as a novel methylation marker of breast cancer.
Kim MS; Lee J; Oh T; Moon Y; Chang E; Seo KS; Hoehn BD; An S; Lee JH
Oncol Rep; 2012 May; 27(5):1681-8. PubMed ID: 22366991
[TBL] [Abstract][Full Text] [Related]
34. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
35.
Mastoraki S; Strati A; Tzanikou E; Chimonidou M; Politaki E; Voutsina A; Psyrri A; Georgoulias V; Lianidou E
Clin Cancer Res; 2018 Mar; 24(6):1500-1510. PubMed ID: 29284708
[No Abstract] [Full Text] [Related]
36. DNA Methylation Cancer Biomarkers: Translation to the Clinic.
Locke WJ; Guanzon D; Ma C; Liew YJ; Duesing KR; Fung KYC; Ross JP
Front Genet; 2019; 10():1150. PubMed ID: 31803237
[TBL] [Abstract][Full Text] [Related]
37. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA BDNF-AS is a potential biomarker and regulates cancer development in human retinoblastoma.
Shang W; Yang Y; Zhang J; Wu Q
Biochem Biophys Res Commun; 2018 Mar; 497(4):1142-1148. PubMed ID: 28131827
[TBL] [Abstract][Full Text] [Related]
39. Exosomes: Insights from Retinoblastoma and Other Eye Cancers.
Lande K; Gupta J; Ranjan R; Kiran M; Torres Solis LF; Solís Herrera A; Aliev G; Karnati R
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992741
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma.
Greger V; Passarge E; Höpping W; Messmer E; Horsthemke B
Hum Genet; 1989 Sep; 83(2):155-8. PubMed ID: 2550354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
